COCRYSTAL PHARMA, INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest
COCRYSTAL PHARMA, INC. (COCP) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest of $53.95 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity · last filed 2016-03-15
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2010-09-30 was $0.00.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for the quarter ending 2010-06-30 was -$460.00.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2015 was $53.95M, a 830.30% increase from fiscal 2014.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2014 was $5.80M, a 41.44% increase from fiscal 2013.
- COCRYSTAL PHARMA, INC. income (loss) from continuing operations, net of tax, attributable to noncontrolling interest for fiscal 2013 was $4.10M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2015-12-31 | $53.95M 10-K · filed 2016-03-15 | ||||
| 2014-12-31 | $5.80M 10-K · filed 2016-03-15 | $5.80M 10-K · filed 2015-03-31 | |||
| 2013-12-31 | $4.10M 10-K · filed 2015-03-31 | ||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$460.00 derived: sum of 2 quarters · filed 2011-11-21 | -$696.00 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | -$460.00 10-Q/A · filed 2011-09-09 | -$696.00 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |